NCT06989775View on ClinicalTrials.gov

BoxX-NoAF Clinical Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

960

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2031

Conditions
Post Operative Atrial FibrillationAtrial Fibrillation, Postoperative
Interventions
DEVICE

Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System

Box lesion ablation with the Isolator Synergy EnCompass Clamp System and LAAE using the AtriClip LAA Exclusion System at the time of planned cardiac surgery

Trial Locations (1)

L8L 2X2

Hamilton General Hospital, Hamilton

Sponsors

Lead Sponsor

AtriCure, Inc.
All Listed Sponsors
lead

AtriCure, Inc.

INDUSTRY

NCT06989775 - BoxX-NoAF Clinical Trial | Biotech Hunter | Biotech Hunter